NCT06609811View on ClinicalTrials.gov

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 21, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 17, 2025

Conditions
Influenza
Interventions
BIOLOGICAL

Intranasal Influenza Live Attenuated Vaccine

This vaccine is produced by Changchun BCHT Biotechnology Co.

BIOLOGICAL

Intranasal Influenza Live Attenuated Vaccine

This vaccine is produced by Changchun BCHT Biotechnology Co.

Trial Locations (1)

Unknown

Haizhou District Center for Disease Control and Prevention, Lianyungang

All Listed Sponsors
lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT06609811 - The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine | Biotech Hunter | Biotech Hunter